24.8 C
New York
Saturday, June 6, 2026

Tag: warranty

HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES SECOND QUARTER 2025 RESULTS

GLEN ALLEN, Va., July 30, 2025 /PRNewswire/ -- Hamilton Beach Brands Holding Company (NYSE: HBB) (The Company) today announced results for the second quarter of 2025. Second Quarter...

FranklinWH Approved by Brighte, Advancing Home Battery Storage Accessibility for Australian Homes

SYDNEY, July 30, 2025 /PRNewswire/ -- FranklinWH Australia Pty Ltd. (FranklinWH Australia), a leading global provider of home energy management and storage systems, is officially approved...

Telix H1 2025 Results: Investor Webcast Notification

MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial...

Telix H1 2025 Results: Investor Webcast Notification

MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025.

Purple Innovation Reports Second Quarter 2025 Results; Reaffirms 2025 Guidance

Net Loss Exceeded Expectations; Adjusted EBITDA Margin Improved 120 Basis Points versus Last Year Strong Rejuvenate 2.0 Demand More than Double the Rejuvenate 1.0 Launch...

POLARIS OFF ROAD EXPANDS 2026 FAMILY LINEUP, WHILE CELEBRATING THE 40TH ANNIVERSARY OF POLARIS ATVS

All-New RANGER 500 Joins the Lineup, an Entry Level UTV in the Value Segment Entire Portfolio Showcases the Brand's Commitment to Rider-Driven Innovation and American...

POLARIS INTRODUCES THE ALL-NEW RANGER 500, STARTING AT UNDER $10,000

Built to deliver value and versatility to help make outdoor chores easier MINNEAPOLIS, July 29, 2025 /PRNewswire/ -- Polaris Off Road, the world leader in...

Growers Edge Acquires FarmTest to Help Retailers and Manufacturers Deliver Proven Product Performance

Automated trial technology helps retailers and manufacturers easily conduct advanced plot and strip trials
Automated trial technology helps retailers and manufacturers easily conduct advanced plot and strip trials

Twinstake releases industry-leading ETH Activation & Exit Calculator

NEW YORK, July 29, 2025 /PRNewswire/ -- Twinstake, the premier non-custodial staking provider for institutional clients, has released its groundbreaking ETH Activation & Exit...

Trawick International Announces Strategic Partnership with AmTrust to Enhance Travel Insurance Offerings

MIAMI, July 29, 2025 (GLOBE NEWSWIRE) -- Trawick International, a leading provider of international travel insurance and assistance services, is proud to announce a new strategic partnership with AmTrust Financial Services, Inc., a global powerhouse in specialty insurance solutions.

Enphase Energy Launches Next-Generation Battery System for Smarter, Simpler Home Power

FREMONT, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of the 4th-generation Enphase® Energy System, featuring the IQ® Battery 10C, IQ® Meter Collar, and the IQ® Combiner 6C. This next-generation system stands out for its smaller footprint, enhanced features, easier installation, and unmatched reliability. Watch a video about the new Enphase system here.

MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy

Zurich, July 29, 2025 – MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the European Medicines Agency has granted Orphan Drug Designation (ODD) to its lead compound, MP1032 for the treatment of children affected by Duchenne muscular dystrophy (DMD). This milestone follows the U.S. FDA's ODD, underscoring MP1032's potential as a first-in-class therapy that could minimize reliance on high-dose corticosteroids, which cause severe side effects like osteoporosis, growth stunting, and metabolic issues.

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsWarranty